Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats

The SARS-CoV-2 pandemic have been affecting millions of people worldwide, since the beginning of 2020. COVID-19 can cause a wide range of clinical symptoms, which varies from asymptomatic presentation to severe respiratory insufficiency, exacerbation of immune response, disseminated microthrombosis...

Full description

Bibliographic Details
Main Authors: Everidiene K. V. B. Silva, Camila G. Bomfim, Ana P. Barbosa, Paloma Noda, Irene L. Noronha, Bianca H. V. Fernandes, Rafael R. G. Machado, Edison L. Durigon, Sergio Catanozi, Letícia G. Rodrigues, Fabiana Pieroni, Sérgio G. Lima, Walcy R. Teodoro, Zelita A. J. Queiroz, Lizandre K. R. Silveira, Ives Charlie-Silva, Vera L. Capelozzi, Cristiane R. Guzzo, Camilla Fanelli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129034/?tool=EBI